Vision

 To realize the potential of precision medicine for patients living with neurodegenerative diseases

 To characterize patients affected by neurodegenerative diseases –not to understand diseases, but to understand how individuals are affected by them.

Mission

 To re-define Parkinson disease and Alzheimer’s disease from a biological standpoint classifying individual patients into distinctive molecular subtypes

 To identify small but molecularly suitable subsets of subjects for embedded proof-of-concept adaptive clinical trials

 To use biological data to match the right patient to the right therapy

STUDY TIMELINE

• Months 0-6: Administrative preparation; database creation

• Months 6-72: Recruitment of 4000 patients and 1000 healthy controls with initial annual follow-up

• Months 72-120: Finish Data Collection, completion of data analysis and follow-up

Click here to learn more

• Twitter
• Facebook